Dirk Kersten, Director at Dyne Therapeutics, Inc. (DYN), sold 5,974 shares at $35.06 ($210K) on 2024-09-25, disclosed to the SEC on 2024-09-27.
Scheduled sale ($210k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $35.06 | 2,357 | $83K | 39.4% |
| 2 | $35.06 | 2,357 | $83K | 39.4% |
| 3 | $35.29 | 1,260 | $44K | 21.2% |
| Total | $35.11 avg | 5,974 | $210K | 100% |
| Filing → |
| DYN | SELL | 2026-06-22 | $1.7M | — | Filing → |
| DYN | SELL | 2026-04-23 | $219K | — | Filing → |
| DYN | SELL | 2026-04-21 | $6.8M | — | Filing → |